Turn Therapeutics Stock Price, News & Analysis
TTRX
NASDAQ
Company Description
Welcome to the overview page for Turn Therapeutics (TTRX), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
No SEC filings available for Turn Therapeutics.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
JAN
01
January 1, 2026 - December 31, 2026
Clinical
GX-03 topline results
Anticipated topline results from Phase 2 eczema trial in 2026
JAN
01
January 1, 2026 - April 30, 2026
Clinical
Topline data release
Announcement of topline data from GX-03 severe eczema program
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Turn Therapeutics (TTRX)?
The current stock price of Turn Therapeutics (TTRX) is $3.27 as of November 21, 2025.
What is the market cap of Turn Therapeutics (TTRX)?
The market cap of Turn Therapeutics (TTRX) is approximately 79.8M. Learn more about what market capitalization means .